These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26935421)

  • 1. Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma.
    Kadariya Y; Menges CW; Talarchek J; Cai KQ; Klein-Szanto AJ; Pietrofesa RA; Christofidou-Solomidou M; Cheung M; Mossman BT; Shukla A; Testa JR
    Cancer Prev Res (Phila); 2016 May; 9(5):406-414. PubMed ID: 26935421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation as a chemoprevention target in asbestos-induced malignant mesothelioma.
    Kadariya Y; Sementino E; Shrestha U; Gorman G; White JM; Ross EA; Clapper ML; Neamati N; Miller MS; Testa JR
    Carcinogenesis; 2022 Dec; 43(12):1137-1148. PubMed ID: 36355620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesothelioma.
    Chow MT; Tschopp J; Möller A; Smyth MJ
    Immunol Cell Biol; 2012 Nov; 90(10):983-6. PubMed ID: 23010873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.
    Menges CW; Kadariya Y; Altomare D; Talarchek J; Neumann-Domer E; Wu Y; Xiao GH; Shapiro IM; Kolev VN; Pachter JA; Klein-Szanto AJ; Testa JR
    Cancer Res; 2014 Feb; 74(4):1261-1271. PubMed ID: 24371224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma.
    Westbom C; Thompson JK; Leggett A; MacPherson M; Beuschel S; Pass H; Vacek P; Shukla A
    PLoS One; 2015; 10(12):e0145404. PubMed ID: 26689911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines involved in the early inflammatory response and in pro-tumoral activity in asbestos-exposed workers from an Italian coastal area with territorial clusters of pleural malignant mesothelioma.
    Comar M; Zanotta N; Zanconati F; Cortale M; Bonotti A; Cristaudo A; Bovenzi M
    Lung Cancer; 2016 Apr; 94():61-7. PubMed ID: 26973208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.
    Sneddon S; Patch AM; Dick IM; Kazakoff S; Pearson JV; Waddell N; Allcock RJN; Holt RA; Robinson BWS; Creaney J
    BMC Cancer; 2017 Jun; 17(1):396. PubMed ID: 28577549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2, epidermal growth factor receptor, and aromatase signaling in inflammation and mesothelioma.
    Nuvoli B; Galati R
    Mol Cancer Ther; 2013 Jun; 12(6):844-52. PubMed ID: 23729401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model recapitulating molecular features of human mesothelioma.
    Altomare DA; Vaslet CA; Skele KL; De Rienzo A; Devarajan K; Jhanwar SC; McClatchey AI; Kane AB; Testa JR
    Cancer Res; 2005 Sep; 65(18):8090-5. PubMed ID: 16166281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism.
    Deswaerte V; Nguyen P; West A; Browning AF; Yu L; Ruwanpura SM; Balic J; Livis T; Girard C; Preaudet A; Oshima H; Fung KY; Tye H; Najdovska M; Ernst M; Oshima M; Gabay C; Putoczki T; Jenkins BJ
    Cancer Res; 2018 Mar; 78(5):1293-1307. PubMed ID: 29282220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response modeling of NLRP3 inflammasome-mediated diseases: asbestos, lung cancer, and malignant mesothelioma as examples.
    Cox LA
    Crit Rev Toxicol; 2019 Aug; 49(7):614-635. PubMed ID: 31905042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: evidence from an animal model and a human cohort.
    Robinson C; Alfonso H; Woo S; Olsen N; Bill Musk AW; Robinson BW; Nowak AK; Lake RA
    Lung Cancer; 2014 Oct; 86(1):29-34. PubMed ID: 25175318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.
    Carbone M; Yang H
    Clin Cancer Res; 2012 Feb; 18(3):598-604. PubMed ID: 22065079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CREB-induced inflammation is important for malignant mesothelioma growth.
    Westbom CM; Shukla A; MacPherson MB; Yasewicz EC; Miller JM; Beuschel SL; Steele C; Pass HI; Vacek PM; Shukla A
    Am J Pathol; 2014 Oct; 184(10):2816-27. PubMed ID: 25111229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Alteration of Human T Cells Exposed Continuously to Asbestos.
    Kumagai-Takei N; Yamamoto S; Lee S; Maeda M; Masuzzaki H; Sada N; Yu M; Yoshitome K; Nishimura Y; Otsuki T
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.
    Kettunen E; Savukoski S; Salmenkivi K; Böhling T; Vanhala E; Kuosma E; Anttila S; Wolff H
    BMC Cancer; 2019 May; 19(1):507. PubMed ID: 31138176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention.
    Toyokuni S
    Free Radic Biol Med; 2019 Mar; 133():206-215. PubMed ID: 30312759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma.
    Lecomte C; Andujar P; Renier A; Kheuang L; Abramowski V; Mellottee L; Fleury-Feith J; Zucman-Rossi J; Giovannini M; Jaurand MC
    Cell Cycle; 2005 Dec; 4(12):1862-9. PubMed ID: 16319530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload signature in chrysotile-induced malignant mesothelioma.
    Jiang L; Akatsuka S; Nagai H; Chew SH; Ohara H; Okazaki Y; Yamashita Y; Yoshikawa Y; Yasui H; Ikuta K; Sasaki K; Kohgo Y; Hirano S; Shinohara Y; Kohyama N; Takahashi T; Toyokuni S
    J Pathol; 2012 Nov; 228(3):366-77. PubMed ID: 22864872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of malignant peritoneal mesothelioma without asbestos exposure: cytologic and immunohistochemical features.
    Kinoshita Y; Takasu K; Yuri T; Yoshizawa K; Uehara N; Kimura A; Miki H; Tsubura A; Shikata N
    Ann Diagn Pathol; 2013 Feb; 17(1):99-103. PubMed ID: 22784439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.